Zipp, Frauke

Prof. Dr. Zipp is Director of the Clinic and Polyclinic for Neurology at Johannes Gutenberg University Mainz. She has been a board member of the Multiple Sclerosis Competence Network since March 2013 and currently serves as deputy spokesperson.

Since 2009: Director of the Clinic and Polyclinic for Neurology at Johannes Gutenberg University Mainz and member of the Rhine-Main Neuronet (rmn2)2006-2009: Director of the Cecilie Vogt Clinic, Charité Berlin, and Clinical Coordinator at the Max Delbrück Center for Molecular Medicine, Berlin

2002-2006: Director of the Institute of Neuroimmunology, Charité Berlin

1998-2002: Senior physician in neurology, Charité Berlin

1996: Visiting scientist, National Institute of Health in Bethesda, USA

1995-1998: Assistant physician, Neurological Clinic of the Eberhard Karls University of Tübingen

1998: Habilitation, Eberhard Karls University of Tübingen

  • Neuroimmunology (Conference Chair of the International Congress of Neuroimmunology, ISNI)
  • Biomarkers, neurodegeneration, neuroregeneration
  • Genetics (Member of the Steering Committee of the International Multiple Sclerosis Genetics Consortium (IMSGC))
  • Therapy development (BMBF VIP+ validation funding for therapy development; member of the international network PMSA (Progressive Multiple Sclerosis Alliance), project BRAVEinMS “Bioinformatics and cell Reprogramming to develop an in vitro platform to discover new drugs for progessive Multiple Sclerosis”)
  • Council member of the European Society for Treatment and Research in Multiple Sclerosis (ECTRIMS)
  • Executive Board Member of the International Medical and Scientific Board of the International MS Federation with Immunization Commission (MSIF)
  • Founding and co-spokesperson of the Transregional Collaborative Research Center (CRC-TR-128) “Initiation/effector and regulatory mechanisms in multiple sclerosis – from a new understanding of pathogenesis to therapy”
  • Founding member and board member of the German Research Foundation Excellence Initiative “NeuroCure”, Charité – Universitätsmedizin Berlin
  • Founding spokesperson of the Collaborative Research Center (CRC-TR-43) “The brain as a target of inflammatory processes”
  • Board member of the Medical Advisory Board of the German Multiple Sclerosis Society (DMSG)
  • Member of the Research Council of the Rhine-Main Universities
  • Deputy Chairwoman of the Council for Technology of the Government of Rhineland-Palatinate

Member of the National and European Academy of Sciences
Since 2011 Leopoldina | Since 2017 Academia europaea)
Alexander Karl Prize (2011)
Heinrich Pette Prize (2005)
Lancet paper received the Nils Ilja Richter Prize (2003)
Research Award of the DPC Academy for Clinical Diagnostics (1999)
Langheinrich Prize (1998)